ALTEPLASE

Cancer

M.D. Anderson Cancer Centerprotein_peptideEarly Phase 1Active

C

38/ 100

Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence: 24/ 100
Competitive Position: 81/ 100

Competitive context

1379 Active assets in the Cancer cohort.

Asset / Sponsor	Phase	Rating
Nabiximols Jazz Pharmaceuticals	Phase 3	BBB
Vitamin B6 M.D. Anderson Cancer Center	Phase 4	BB
Rivoceranib Jiangsu HengRui Medicine Co., Ltd.	Phase 4	BB
Desflurane Peter MacCallum Cancer Centre, Australia	Phase 4	BB
PROPOFOL Hong Kong Children's Hospital	Phase 4	BB

View all 50 →

Same molecule, other indications

ALTEPLASE is also rated in:

ischemic strokeActive

BB

Indicative · Phase 4

70 / 100

stroke disorderActive

BB

Indicative · Phase 4

70 / 100

brain infarctionActive

BB

Indicative · Phase 4

68 / 100

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.